Minority recruitment in hereditary breast cancer research

被引:0
|
作者
Hughes, C
Peterson, SK
Ramirez, A
Gallion, KJ
McDonald, PG
Skinner, CS
Bowen, D
机构
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA
[4] Baylor Coll Med, Chron Dis Prevent & Control Res Ctr, Houston, TX 77030 USA
[5] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[6] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27706 USA
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although recruitment of ethnic and racial minorities in medical research has been evaluated in several studies, much less is known about the methods used to recruit these populations to participate in cancer genetics research. This report reviews the resources that have been used to identify and recruit ethnic and racial minorities to participate in hereditary breast cancer research. Overall, hospital-based resources were used most often to identify potential subjects, and active recruitment methods were used most frequently to enroll eligible subjects. This review suggests that there appears to be a finite number of resources and strategies to identify and recruit potential subjects to participate in cancer genetics research; however, options for improving awareness about cancer genetics research among ethnic and racial minorities have not been extensively evaluated. To study ethnic and racial minority participation in cancer genetics research, stronger evaluation components will need to be integrated into research methods. Both observational and experimental studies are needed to determine resources that are most effective for identifying potential subjects who are ethnic and racial minorities and to evaluate the effects of different recruitment strategies on enrollment decisions among these populations.
引用
收藏
页码:1146 / +
页数:11
相关论文
共 50 条
  • [41] The prevention of hereditary breast cancer
    Rodriquez, Estelarnari
    Domchek, Susan M.
    [J]. SEMINARS IN ONCOLOGY, 2007, 34 (05) : 401 - 405
  • [42] Hereditary breast and ovarian cancer
    Sullcahuaman-Allende, Yasser
    Arias-Velasquez, Abelardo
    [J]. REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2008, 54 (03): : 194 - 198
  • [43] Pathology of hereditary breast cancer
    van der Groep, Petra
    van der Wall, Elsken
    van Diest, Paul J.
    [J]. CELLULAR ONCOLOGY, 2011, 34 (02) : 71 - 88
  • [44] Korean Hereditary Breast Cancer
    Kim, Sung-Won
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (10): : 952 - 962
  • [45] Prophylaxis of hereditary breast cancer
    de Groot, Jolien S.
    van Diest, Paul J.
    Derksen, Patrick W. B.
    [J]. AGING-US, 2017, 9 (12): : 2453 - 2454
  • [46] The "portait" of hereditary breast cancer
    Lacroix, M
    Leclercq, G
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (03) : 297 - 304
  • [47] Pathology of hereditary breast cancer
    Da Silva, Leonard
    Lakhani, Sunil R.
    [J]. MODERN PATHOLOGY, 2010, 23 : S46 - S51
  • [48] The pathology of hereditary breast cancer
    Lakhani, SR
    [J]. DISEASE MARKERS, 1999, 15 (1-3) : 113 - 114
  • [49] Anticipation in hereditary breast cancer
    Dagan, E
    Gershoni-Baruch, R
    [J]. CLINICAL GENETICS, 2002, 62 (02) : 147 - 150
  • [50] Hereditary breast and ovarian cancer
    Jacek Gronwald
    Tomasz Byrski
    Tomasz Huzarski
    Oleg Oszurek
    Anna Janicka
    Jolanta Szymańska-Pasternak
    Bohdan Górski
    Janusz Menkiszak
    Izabella Rzepka-Górska
    Jan Lubiński
    [J]. Hereditary Cancer in Clinical Practice, 6